Gert Mayer

4.5k total citations · 1 hit paper
58 papers, 1.4k citations indexed

About

Gert Mayer is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Gert Mayer has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 23 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Surgery. Recurrent topics in Gert Mayer's work include Chronic Kidney Disease and Diabetes (23 papers), Diabetes Treatment and Management (23 papers) and Dialysis and Renal Disease Management (10 papers). Gert Mayer is often cited by papers focused on Chronic Kidney Disease and Diabetes (23 papers), Diabetes Treatment and Management (23 papers) and Dialysis and Renal Disease Management (10 papers). Gert Mayer collaborates with scholars based in Austria, Netherlands and Germany. Gert Mayer's co-authors include Paul Perco, Johannes Leierer, Hiddo J.L. Heerspink, Andreas Kronbichler, Andreas Heinzel, Michael K. Hansen, Skander Mulder, Jae Il Shin, Herbert Tilg and Maria Effenberger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Gert Mayer

58 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

2019 340 citations Hiddo J.L. Heerspink, Paul Perco et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gert Mayer Austria	20	459	459	333	260	213	58	1.4k
Mark W. Donoghoe Australia	16	128 0.3×	250 0.5×	180 0.5×	216 0.8×	139 0.7×	53	1.1k
W. Marieke Schoonen United Kingdom	12	204 0.4×	163 0.4×	202 0.6×	235 0.9×	276 1.3×	18	2.2k
Lingyi Lu United States	22	243 0.5×	142 0.3×	358 1.1×	79 0.3×	93 0.4×	56	1.4k
Laurent Remontet France	26	120 0.3×	272 0.6×	118 0.4×	390 1.5×	326 1.5×	101	2.2k
Tina Yen United States	31	611 1.3×	635 1.4×	435 1.3×	1.2k 4.7×	173 0.8×	130	2.9k
Jonas Axelsson Sweden	19	626 1.4×	112 0.2×	101 0.3×	236 0.9×	244 1.1×	50	1.2k
Susan C. Pitt United States	27	274 0.6×	1.1k 2.3×	179 0.5×	1.0k 3.9×	597 2.8×	106	2.6k
Bin Yi China	20	170 0.4×	49 0.1×	356 1.1×	175 0.7×	450 2.1×	76	1.7k
Sudesh Srivastav United States	25	57 0.1×	196 0.4×	264 0.8×	436 1.7×	114 0.5×	87	1.7k
Fen Liu China	21	50 0.1×	209 0.5×	296 0.9×	276 1.1×	377 1.8×	154	1.7k

Countries citing papers authored by Gert Mayer

Since Specialization

Citations

This map shows the geographic impact of Gert Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Mayer more than expected).

Fields of papers citing papers by Gert Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Mayer. The network helps show where Gert Mayer may publish in the future.

Co-authorship network of co-authors of Gert Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Gert Mayer. A scholar is included among the top collaborators of Gert Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert Mayer. Gert Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schunk, Stefan, Susanne Eder, Johannes Leierer, et al.. (2025). Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care. Diabetes. 75(1). 144–153. 1 indexed citations

Reinstadler, Vera, Susanne Eder, Hiddo J.L. Heerspink, et al.. (2024). Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia. 67(7). 1283–1294. 3 indexed citations

Siwy, Justyna, Susanne Eder, Gert Mayer, et al.. (2023). Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment. International Journal of Molecular Sciences. 24(17). 13540–13540. 2 indexed citations

Eder, Susanne, László Rosivall, Andrzej Więcek, et al.. (2023). International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe. Kidney & Blood Pressure Research. 48(1). 165–174. 2 indexed citations

Gauckler, Philipp, Johannes Leierer, Michael Schreinlechner, et al.. (2023). Exercise-Induced Fluid Retention, Cardiac Volume Overload, and Peripheral Edema in Ultra-Distance Cyclists. Kidney International Reports. 9(1). 152–161. 1 indexed citations

Nair, Viji, Johannes Leierer, Michael Rudnicki, et al.. (2022). Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Biomolecules. 13(1). 89–89. 4 indexed citations

Mayer, Gert, et al.. (2022). Biological variation and reference change value of the estimated glomerular filtration rate in humans: A systematic review and meta-analysis. Frontiers in Medicine. 9. 1009358–1009358. 10 indexed citations

Säemann, Marcus D., Daniel Cejka, Sabine Schmaldienst, Alexander R. Rosenkranz, & Gert Mayer. (2022). Value of SGLT-2 inhibitors in the treatment of chronic kidney disease. Wiener klinische Wochenschrift. 135(3-4). 97–109. 3 indexed citations

Effenberger, Maria, Andreas Kronbichler, Felix Grabherr, et al.. (2021). Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. Journal of Medical Internet Research. 23(8). e21656–e21656. 3 indexed citations

10.

Perco, Paul, et al.. (2021). Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review. Journal of Diabetes and its Complications. 35(7). 107931–107931. 19 indexed citations

11.

Effenberger, Maria, Andreas Kronbichler, Jae Il Shin, et al.. (2020). Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis. International Journal of Infectious Diseases. 95. 192–197. 177 indexed citations

12.

Mayer, Gert, Christoph Wanner, Matthew R. Weir, et al.. (2019). Analysis from the EMPA-REG OUTCOME® trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics. Kidney International. 96(2). 489–504. 71 indexed citations

13.

Sourij, Harald, Friedrich C. Prischl, Martin Auinger, et al.. (2019). Diabetische Nierenerkrankung (Update 2019). Wiener klinische Wochenschrift. 131(S1). 151–163. 2 indexed citations

14.

Kronbichler, Andreas, Philipp Gauckler, Keum Hwa Lee, et al.. (2019). Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?. Atherosclerosis Supplements. 40. 55–60. 9 indexed citations

15.

Kronbichler, Andreas, Jun Oh, Björn Meijers, Gert Mayer, & Jae Il Shin. (2017). Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy. BioMed Research International. 2017. 1–14. 12 indexed citations

16.

Khurana, Rimpi, et al.. (2016). Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA. 23(2). 142–152. 123 indexed citations

17.

Dienemann, Thomas, Naohiko Fujii, Paula Orlandi, et al.. (2016). International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts. BMC Nephrology. 17(1). 121–121. 36 indexed citations

18.

Zoccali, Carmine, Àngel Argilés, Mustafa Arıcı, et al.. (2015). The fate of triaged and rejected manuscripts. Nephrology Dialysis Transplantation. 30(12). 1947–1950. 5 indexed citations

19.

Mann, Johannes F.E., Peter Rossing, Andrzej Więcek, et al.. (2015). Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?. Nephrology Dialysis Transplantation. 30(suppl 4). iv1–iv5. 6 indexed citations

20.

Pena, Michelle J., Dick de Zeeuw, Harald Mischak, et al.. (2015). Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrology Dialysis Transplantation. 30(suppl 4). iv86–iv95. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact